Human urinary kininogenase reduces the endothelial injury by inhibiting Pyk2/MCU pathway.
Yang X, Li Z, Zhang Y, Bu K, Tian J, Cui J, Qin J, Zhao R, Liu S, Tan G, Liu X.
Yang X, et al.
Biomed Pharmacother. 2021 Nov;143:112165. doi: 10.1016/j.biopha.2021.112165. Epub 2021 Sep 17.
Biomed Pharmacother. 2021.
PMID: 34543986
Free article.
Human urinary kallidinogenase (HUK) is a tissue kallikrein which is used for ischemia-reperfusion injury treatment. Studies have shown that HUK may be a potential therapeutic agent to prevent stenosis after vascular injury, however, the precise mechanisms have not been ful …
Human urinary kallidinogenase (HUK) is a tissue kallikrein which is used for ischemia-reperfusion injury treatment. Studies have shown that …